Andes Biotechnologies Global Inc. — Form D

Andes Biotechnologies Global Inc. of BURLINGAME, CA, a company, filed a Form D exempt-offering notice with the SEC on 2017-12-15. The offering totals $15.0M, of which $2.2M was reported sold. Industry: Biotechnology.

Offering

• Filed: 2017-12-15
• Form: D
• Accession: 0001725267-17-000001
• Industry: Biotechnology
• Exemptions: 06b
• Total offering: $15.0M
• Amount sold: $2.2M
• Remaining: $12.8M
• Investors: 20
• Date of first sale: 2017-11-30
• Security types: debt
• Revenue range: Decline to Disclose
• SEC file number: 021-300898

Issuer

• Name: Andes Biotechnologies Global Inc.
• CIK: 0001725267
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Incorporated: 2017
• Address: 863 MITTEN ROAD, SUITE 101, BURLINGAME, CA, 94010
• Phone: 56-22367-2000

Officers, directors & promoters (2)

More

• CIK 1725267 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search